FdaApplication

NDA 050625

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date1990-03-02

Products (3)

ProductActive ingredientStrengthDosage form
SANDIMMUNECYCLOSPORINE100MGCAPSULE;ORAL
SANDIMMUNECYCLOSPORINE50MGCAPSULE;ORAL
SANDIMMUNECYCLOSPORINE25MGCAPSULE;ORAL

3 products